Note: Ingredients listed on restricted chemical lists
EC/CAS
238-878-4/14808-60-7
Name of the chemical
Silica, crystalline
Concentration
>=90-<=100
General Information
Version
1.5
Revision date
2024-09-27
Product name
SIKRON SD 800
CAS No.
14808-60-7
1.2.1 Relevant identified uses
Main applications (non exhaustive list): paint, ceramics, glass fibre, adhesives, plastics, rubber sealants, special concrete, manufacture of silicon, ferrosilicon and ironoxide pellets. Addi- tive in production of cement and concrete. Fluxing material
Emergency telephone
+4922341010, +49 (0)2234-101-700
Icons in SDS
Company Information
company name
Quarzwerke GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
msds@quarzwerke.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H372
Hazard statements
Code
Statements
H372
Causes damage to organs through prolonged or repeated exposure
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H372 Causes damage to organs (Lungs) through pro- longed or repeated exposure if inhaled.
Prevention
P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this prod- uct.
Response
P314 Get medical advice/ attention if you feel unwell.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Depending on the type of handling and use (e.g. grinding, drying), airborne respirable crystalline silica may be generated. Prolonged and/or massive inhalation of respirable crystalline silica dust may cause lung fibrosis, commonly referred to as silicosis. Principal symptoms of silicosis are cough and breathlessness. Occupational exposure to respirable crystalline silica dust should be monitored and controlled. This product should be handled with care to avoid dust generation.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Specific target organ toxicity - repeated H372: Causes damage to organs through pro- exposure, Category 1, Lungs longed or repeated exposure if inhaled.
